New Key Statistics Module, Z-Score and F-Score
NAS:ACAD Key Ratios
| Market Cap $ M | 2,811.82 |
| Enterprise Value $ M | 2,373.32 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 26.29 |
| Price/Book | 6.51 |
| Price/Sales | 3.84 |
| Price/Free Cash Flow | 174.09 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 726.00 |
| EPS (TTM) $ | -0.38 |
| Beneish M-Score | -1.7 |
| 10-y EBITDA Growth Rate % | 1.10 |
| 5-y EBITDA Growth Rate % | 22.30 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -32.34 |
| EV-to-EBITDA | -34.99 |
| PEG | -- |
| Shares Outstanding M | 164.77 |
| Net Margin (%) | -8.44 |
| Operating Margin % | -10.10 |
| Pre-tax Margin (%) | -7.03 |
| Quick Ratio | 2.28 |
| Current Ratio | 2.42 |
| ROA % (ttm) | -9.38 |
| ROE % (ttm) | -15.60 |
| ROIC % (ttm) | -52.07 |
| Dividend Yield % | -- |
| Altman Z-Score | 1.99 |
ACAD Number of Guru Trades
ACAD Volume of Guru Trades
Gurus Latest Trades with NAS:ACAD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ACAD is held by these investors
Total 1
ACADIA Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:ACAD
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers